Differences in Safety of Non ‐Steroidal Anti‐Inflammatory Drugs in Patients with Osteoarthritis and Rheumatoid Arthritis: A Randomized Clinical Trial

ConclusionsCelecoxib at approved dosages produced similar or lower cardiovascular, gastrointestinal, and renal risk for adverse events compared with ibuprofen and naproxen in OA and RA.This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatism - December 20, 2017 Category: Rheumatology Authors: Daniel H. Solomon, M. Elaine Husni, Katherine E. Wolski, Lisa M. Wisniewski, Jeffrey S. Borer, David Y. Graham, Peter Libby, A. Michael Lincoff, Thomas F. L üscher, Venu Menon, Neville D. Yeomans, Qiuqing Wang, Weihang Bao, Manuela F. Berger, Steven E. N Tags: Full Length Source Type: research